How much revenue does Braxia Scientific make?

Braxia Scientific reported $1.88 million in revenue for fiscal year 2023, up 26.7% from $1.49 million in fiscal year 2022. In Q3 2024 revenue was $492,445.

What companies are similar to Braxia Scientific?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Veritas Farms, Inc. (VFRM), Transnational Cannabis LTD (TRCNF), Body and Mind Inc. (BMMJ), Rainbow International Corp. (RNBI).

Braxia Scientific Corp. (BRAXF) Stock

About Braxia Scientific Corp.

Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery method...

At a glance

Braxia Scientific reported revenue of $1.88 million for fiscal year 2023, up 26.7% from fiscal year 2022, and net income of -$13.14 million. In Q3 2024 (the quarter ended December 31, 2023) revenue was $492,445, up 0.7% from a year before.

Figures from company filings; latest fiscal year ended March 31, 2023.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.